Jennison Associates
IMGN

Jennison Associates’s Immunogen Inc IMGN Stock Holding History

Jennison Associates’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-2,308,596
Closed -$8.87M – 636
2023
Q1 		$8.87M Sell
2,308,596
-6,831,763
-75% -$29.1M 0.01% 403
2022
Q4 		$45.3M Buy
9,140,359
+2,942,879
+47% +$16M 0.05% 197
2022
Q3 		$29.6M Buy
+6,197,480
New +$32.7M 0.03% 259
2019
Q4 		– Sell
-160,014
Closed -$387K – 685
2019
Q3 		$387K Sell
160,014
-461,293
-74% -$1.22M ﹤0.01% 621
2019
Q2 		$1.35M Sell
621,307
-850,369
-58% -$2.01M ﹤0.01% 521
2019
Q1 		$3.99M Buy
1,471,676
+398,855
+37% +$1.73M ﹤0.01% 474
2018
Q4 		$5.15M Sell
1,072,821
-100,539
-9% -$610K 0.01% 481
2018
Q3 		$11.1M Buy
1,173,360
+8,717
+0.7% +$83.8K 0.01% 463
2018
Q2 		$11.3M Buy
+1,164,643
New +$12.3M 0.01% 459

Other funds holding IMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jennison Associates's IMGN Position: Q2 2023 in Review

Jennison Associates sold out of Immunogen Inc (IMGN) in Q2 2023, closing a stake of 2,308,596 shares — an estimated $8.87M sold.

Jennison Associates first reported a position in IMGN in Q2 2018 and held it in 9 quarters. The position peaked at $45.3M in Q4 2022. 266 funds tracked by Wall St. Rank hold IMGN as of Q2 2023.

  • Jennison Associates reported no remaining Immunogen Inc position as of Q2 2023 after selling out during the quarter.
  • Jennison Associates sold 2,308,596 Immunogen Inc shares in Q2 2023, an estimated $8.87M.
  • Jennison Associates first reported a position in Immunogen Inc in Q2 2018 and held it in 9 quarters.
  • Jennison Associates's Immunogen Inc position peaked at $45.3M in Q4 2022.
  • 266 funds tracked by Wall St. Rank held Immunogen Inc as of Q2 2023.

Based on Jennison Associates's 13F filing for Q2 2023, filed 3 Aug 2023.